MedCity News

The US Capitol Building in Washington DC, at an angle, over some trees. The beautiful dome stretches up into the blue sky with scattered clouds.

Bipartisan Lawmakers Are Fighting HHS’ 340B Rebate Push

Recovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA

Replimune went from an FDA rejection to a resubmission, a positive advisory committee vote, and finally an accelerated regulatory approval for advanced melanoma — all in less than four months. The FDA nod for Replimune’s oncolytic viral therapy, Tudriqev, positions it as a more convenient alternative to an Iovance Biotherapeutics cell therapy that had been the only treatment in this setting.

By Frank Vinluan

Policy

Democratic Senators Urge Withdrawal of Interim Final Rule on Medicaid Work Requirements

Democratic senators are urging CMS to withdraw its Medicaid work requirements rule, arguing it will create administrative burdens and cause eligible beneficiaries to lose coverage.

By Marissa Plescia

MedCity Influencers

The Missing Piece of Preventive Dental Care Lies in the Bite

Historically, prevention has focused on protecting teeth from decay and gum disease. However, long-term oral health is also shaped by how the teeth, muscles, and jaw function together over time.

By Dr. Robert B. Kerstein

Latest Video

Latest News

MedCity Influencers

illustration of man crossing surreal road, risk concept black and white risk

Healthcare Workplace Violence Prevention Needs Better Visibility Into Risk Signals

Gaps in prevention are not frequently due to a complete lack of information, but instead the fact that organizations don't have a clear way to see how the pieces fit together until after an incident has occurred.

By Brian Stromberg

Events, Health Tech

INVEST Digital Health Conference Returns with Focus on Consumers

Scheduled for October 29 at Pegasus Park in Dallas, the theme of the INVEST Digital Health conference will be consumers in healthcare from d2c diagnostics to GLP-1 drugs and wearables. Register today!

By Stephanie Baum

BioPharma, Pharma

Moderna Gets FDA Approval for mRNA Flu Vaccine, But CDC Input Still Uncertain

The FDA approved Moderna’s flu vaccine mFLUSIVA, a regulatory decision that comes six months after the agency refused to review the mRNA shot and then quickly reversed its position. But a recommendation from a Centers for Disease Control and Prevention advisory committee is key for payer coverage, and that committee has not met all year due to ongoing litigation.

By Frank Vinluan

Consumer / Employer

Report: What Employers Think About ICHRAs

A new survey found that many employers are considering ICHRAs, though concerns about awareness, affordability and the individual insurance market continue to slow adoption.

By Marissa Plescia

Health Services, Policy, Payers

Debunked Episode 29: CMS GLP-1 Drug Pilot Program, RPM Strategy Raise Questions

At MedCity News’ inaugural Bullseye conference in Chicago, Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed recent CMS actions and Mayo Clinic’s former research director, who has filed a complaint against the medical center over how it’s deploying AI.

By Stephanie Baum

Where Will AI Deployment Benefit Payers the Most?

We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.

By MedCity News

MedCity Influencers

Connecting the Dots: How Oral Health Can Enable Whole-Person Care

The industry has made real progress in recognizing that oral health belongs at the center of whole-person care, but intent alone isn’t enough. To translate this vision into something tangible, the industry must invest in infrastructure that makes integration not only possible but scalable.

By Larry Paul

MedCity Influencers

Should You Centralize Cold Chain Fulfillment? Only If You’ve Solved Distribution First

Cold chain is a logistics problem — not just a throughput problem. Pharmacies must rethink their strategy, not just automate it.

By Alecia Lashier

Artificial Intelligence, Health Tech, Providers

6 Ways UnityPoint Health Is Trying to Make Clinicians’ Jobs Easier

UnityPoint Health's chief medical officer, Gregory Johnson, shared several ways the system is using AI to lift administrative burden off clinicians and get them back to patient care — including ambient scribing, real-time capacity tracking and AI-powered chart review.

By Katie Adams

Payers, Health Tech

Curative, Wondr Health Team Up for Weight and Metabolic Health Support

Curative Insurance Company partnered with Wondr Health to expand weight management support for its members.

By Marissa Plescia

BioPharma, Pharma

Attovia’s Upsized IPO Brings In $289M to Fund New Kind of Biologic for Immune Disorders

Attovia Therapeutics’ biologic medicines could offer advantages over currently available immune disorder drugs, such as Sanofi’s blockbuster medicine Dupixent. The IPO comes as Attovia looks to expand clinical development of its pipeline in 2027.

By Frank Vinluan

MedCity Influencers

The Sleep Crisis We May Be Missing: Why Millions of Americans Remain Undiagnosed

Despite the silk masks, oils, and sleepy girl mocktails swirling around social media, one of the greatest causes of non-restorative sleep is rarely mentioned by wellness influencers online: actual sleep disorders.

By Julie Flygare

MedCity Influencers

The Healthcare Leaders Driving Change Need to Get Better at Explaining It

Healthcare leaders who shape that future need more than innovation. They need a visible, credible voice that helps the people around them — patients, clinicians, employees, partners, and investors — understand what the change is, why it matters, and why this is the right person to lead it.

By Katie Radel

Artificial Intelligence, Startups, BioPharma, Health Tech

QuantHealth Snags $45M to Simulate Clinical Trials Before Patients Ever Enroll

QuantHealth raised $45 million in Series B funding to expand its AI platform, which simulates clinical trials before they run and predicts patient outcomes for pharma companies. The startup is aiming to cut the industry's 90% trial failure rate and speed up the timelines for effective drugs to reach the market.

By Katie Adams

Policy

How Policymakers Can Improve Obesity Treatment and Affordability, Per American College of Physicians

The American College of Physicians is urging policymakers to expand access to obesity treatment and healthy foods while investing in prevention and research.

By Marissa Plescia

BioPharma, Startups, Artificial Intelligence

Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents

Pathos AI struck a deal for rights to a bispecific antibody drug conjugate from Alphamab that could become first in a new class of cancer drugs. Separately, the startup began a partnership with AstraZeneca on a protein degrader from the pharma company's cancer drug pipeline.

By Frank Vinluan